First human trial of QX-4533 begins safety testing
NCT ID NCT07678463
First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This phase 1 trial tests the safety and tolerability of a new drug called QX-4533 in 90 healthy adults aged 18 to 55. Participants receive either single or multiple doses of the drug or a placebo, and the study also looks at how food affects the drug's levels in the body. The goal is to gather early safety data and understand how the drug behaves, which is a necessary step before testing it in people with a specific disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
QX-4533
What this could lead to
If safe, this could pave the way for future studies testing QX-4533 as a potential treatment for an undisclosed condition.
What could go wrong
This is an early-phase trial in healthy volunteers, so it cannot show whether the drug works for any disease. Side effects or lack of tolerability may stop further development.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain Metabolism Study Using PET/fMRI (NCT05756335)
- Short-term arm immobilization & muscle metabolis NCT06750497
- Parent-led app boosts kids' motor & brain skills NCT07680075
- DigiKids App-Based Motor Skills Trial for Kids (NCT07679633)
- Pomegranate Supplement & Gut Health in Alcohol L NCT07678567
- Ketogenic Diet & Heart Risk Study (NCT07675603)
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
103 Carnegie Center
Princeton, New Jersey, 08540, United States